DAM
ZURA icon

DLD Asset Management’s Zura Bio ZURA Stock Holding History

DLD Asset Management’s Portfolio ZURA Stock Details ZURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-100,000
Closed -$433K – 475
2025
Q3 		$433K Buy
+100,000
New +$180K 0.03% 229

Other funds holding ZURA

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

DLD Asset Management's ZURA Position: Q4 2025 in Review

DLD Asset Management sold out of Zura Bio (ZURA) in Q4 2025, closing a stake of 100,000 shares — an estimated $433K sold.

DLD Asset Management first reported a position in ZURA in Q3 2025 and held it in 1 quarter. The position peaked at $433K in Q3 2025. 75 funds tracked by Wall St. Rank hold ZURA as of Q4 2025.

  • DLD Asset Management reported no remaining Zura Bio position as of Q4 2025 after selling out during the quarter.
  • DLD Asset Management sold 100,000 Zura Bio shares in Q4 2025, an estimated $433K.
  • DLD Asset Management first reported a position in Zura Bio in Q3 2025 and held it in 1 quarter.
  • DLD Asset Management's Zura Bio position peaked at $433K in Q3 2025.
  • 75 funds tracked by Wall St. Rank held Zura Bio as of Q4 2025.

Based on DLD Asset Management's 13F filing for Q4 2025, filed 13 Feb 2026.